Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 420 Precursor Cell Lymphoblastic Leukemia-Lymphoma 126 Neoplasms, Plasma Cell 74 Recurrence 70 Lymphoma 57 Leukemia 54 Neoplasms 46 Immunoglobulin Light-chain Amyloidosis 38 Burkitt Lymphoma 37 Vomiting 36 Lymphoma, Mantle-Cell 32 Lymphoma, Large B-Cell, Diffuse 31 Nausea 29 Lymphoma, Non-Hodgkin 28 Breast Neoplasms 22 Waldenstrom Macroglobulinemia 21 Lymphoma, Follicular 21 Hodgkin Disease 21 Leukemia, Lymphocytic, Chronic, B-Cell 20 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17 Neoplasm Metastasis 17 Prostatic Neoplasms 16 Lymphoma, Extranodal NK-T-Cell 16 Amyloidosis 16 Leukemia, Myeloid, Acute 15 Smoldering Multiple Myeloma 14 Lymphoma, B-Cell, Marginal Zone 13 Lung Neoplasms 11 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, B-Cell 10

Interventions

selinexor 1 pegfilgrastim 1 midostaurin 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Aggression × Dexamethasone × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡